Moreover, the drug T1AM increases SIRT6 levels, whereas it decreases SIRT4 levels, as well as reversing obesity through metabolic reprogramming [378]. This evidence concerns the gene SIRT4 and obesity due to melanocortin 4 receptor deficiency.